In this study, we developed an extracellular vesicle liquid biopsy to identify miRNA biomarkers packaged within HER2+ and CD24+ plasma EVs for the classification of malignancy in women with BI-RADS 4 breast lesions. This evidence concerns the gene ERBB2 and medical procedure.